AI assistant
CENTENE CORP — Director's Dealing 2011
Feb 22, 2011
30343_dirs_2011-02-22_cafe769f-7aba-4cb1-bf0d-2c5d56f2ae16.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CENTENE CORP (CNC)
CIK: 0001071739
Period of Report: 2011-02-18
Reporting Person: Mason Mary V (SVP & Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-18 | Phantom Stock | $0 | A | 49.557 | Acquired | 2011-02-18 | Common Stock (49.557) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 21790 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Common Stock Option (right to buy) | $26.29 | 2016-01-03 | Common Stock (7500) | 7500 | Direct |
| Common Stock Option (right to buy) | $28.26 | 2016-04-24 | Common Stock (2000) | 2000 | Direct |
| Common Stock Option (right to buy) | $25.21 | 2016-12-12 | Common Stock (5000) | 5000 | Direct |
Footnotes
F1: Ownership includes previous awards of 14,159 restricted stock units subject to vesting requirements.
F2: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock.
F3: The phantom stock was acquired by Dr. Mason through a payroll contribution to the Company's deferred compensation plan.
F4: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Dr. Mason's termination with the Company or on such other date Dr. Mason may elect.